TrialJournal of cancer research and clinical oncology2023

Effect and outcomes analysis of anlotinib in non-small cell lung cancer patients with liver metastasis: results from the ALTER 0303 phase 3 randomized clinical trial.

Yinchen Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.